The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
Results for: 2021
IHE CEO, Dr. Chris McCabe provided a webinar presentation – “Demonstrating Value in Laboratory Medicine” on July 14th, 2021 as part of the international educational platform Labroots. Data and insights from laboratory tests help guide clinical decision-making, support policy changes, healthcare service planning and can have substantial…
The impact of universal varicella vaccination on herpes zoster (HZ) risk in unvaccinated and vaccinated children, and its long-term influence on HZ epidemiology, remains unknown. This retrospective cohort study used population-based administrative health data for children born between 1993 and 2018. A universal varicella vaccination programme implementation corresponded to decreased…
Dr. Kate Harback, IHE Associate Director of Economics will be participating in a National Academy of Sciences workshop – “Aviation After a Year of Pandemic – Economics, People and Technology”. The workshop will examine what the future aviation industry will look like after a year of COVID-19? The virtual workshop will take place on June 28-30, 2021 from 12-4:30pm ET and focus…
The objective of this study was to implement a model-based approach to identify the optimal allocation of a coronavirus disease 2019 (COVID-19) vaccine in the province of Alberta Canada. The results have three important policy implications: (i) optimal vaccine allocation will depend on the public health policies in place at the time of allocation and the impact of those policies…
The IHE is part of a research team funded by Alberta Innovates to investigate how widespread cannabis use is among arthritis patients. Self-medication and a lack of solid evidence to guide cannabis use for these purposes can lead to substantial harm. The research team will develop and validate a decision tool to help guide cannabis use to inform patients and health professionals.…
IHE Director of Economics Dr. Jeff Round participates in an interview with other colleagues for Global News about the pros and cons of using incentives to encourage members of the public to get vaccinated. Link: https://globalnews.ca/news/7902049/alberta-covid-19-vaccine-incentives/
Merck Canada Joins Synthetic Data Project Edmonton, AB, May 11, 2021 – Health City and the Institute of Health Economics (IHE) are pleased to welcome Merck Canada as a new partner to an innovative Alberta collaboration aimed at exploring the potential uses for synthetic health data. Merck Canada will be joining existing partners Alberta Innovates and the University of Alberta,…
IHE CEO leads national team to model full impact of pandemic restrictions Model to be used to predict unintended consequences, advise decision-makers during next public health crisis. April 14th, 2021 - While the COVID-19 pandemic continues its grip on Canada’s health-care system and economy,…
Be part of our growth! IHE is hiring for a variety of positions to support our growing program of work. There are a number of opportunities to work and/or train with the Institute of Health Economics (IHE). https://www.ihe.ca/about/careers-awards Senior Health Economist: The Institute of Health Economics is recruiting a Senior Health Economist to provide leadership on projects…
Location: Canada Date of Posting: June 1, 2021 Deadline for Application: : Open until filled. All applications received on or before June 21, 2021 will be given full consideration. Time Commitment: Full-time Term: 2 years Reference Number: 21-005 Be part of our growth! IHE is hiring for a variety of positions to support our growing program of work. The Institute of Health Economics…
The COVID Strategic Choices Group is an interdisciplinary taskforce with experience across different domains of expertise (including epidemiology, public health, public policy, economics and business) and regions of Canada. IHE CEO, Dr. Christopher McCabe is a member of the COVID Strategic Choices Group. Members serve in their individual capacity and not as representatives of any…
This special supplement of Clinical Laboratory News showcases the winning teams from the UNIVANTS Healthcare Excellence Awards. It features innovative programs in Laboratory Medicine. The Institute of Health Economics is pleased to be one of the partners and judges in this prestigious program. Approximately 180 applications were initiated and three top-performing teams were selected…
The Institute for Health Economics (IHE) CEO co-authored an opinion editorial appearing in the Edmonton Journal with Timothy Caulfield, Dr. James Talbot and Dr. Noel Gibney. In it Dr. McCabe and fellow authors provide a critique of a previous editorial, appearing on February 8th, by Dr. Ari R. Joffe and Mr. David Redman. The concluding message of the editorial is: “Going forward,…
New report highlights importance of Stem Cell sector in Canada and opportunities for future competitiveness and contributions to economic recovery The Institute for Health Economics (IHE) has published a report which provides an overview of the current state and future prospects for stem cell/regenerative medicine in Canada. Specifically, it assesses the strengths, potential areas…
The purpose of this report is to provide a summary of current information and stakeholder perspectives regarding the current and future state of regenerative medicine (with a focus on stem cell-based research) in Canada and globally. Specifically, it assesses the strengths, potential areas for improvement, and opportunities for growth in the Canadian sector to ensure the future…
Little is currently known about the overall health service utilization and cost burden in patients with high risk for cardiovascular disease (HRCVD) who are recommended to start a statin to control dyslipidemia to prevent CVD events and mortality in short- and long-term care. We assessed the resource use and healthcare cost burden in this HRCVD patient population in Alberta, Canada,…
There are a number of opportunities to work and/or train with the Institute of Health Economics (IHE) to design and conduct model-based economic evaluations of emerging health care technologies. (see below). Health Economist / Mathematical modeler 12 Month Training Position(s): The IHE is recruiting up to two (2) candidates for a twelve (12) training position, with strong potential…
The Institute for Health Economics (IHE) conducted a roundtable on PF-ILD, in November 2021 and policy recommendations from the diverse stakeholder group provided some guidance on areas to focus on to improve the lives of those living with progressive fibrosing interstitial lung disease. Key actions identified at the roundtable included: increased surveillance for early identification…
A national roundtable provides direction for key components that should be included in national strategies to optimize care for patients with progressive fibrosing interstitial lung disease (PF-ILD). The Institute for Health Economics (IHE) conducted an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This…
